New prospects for vinblastine analogues as anticancer agents

Journal of Medicinal Chemistry

Volumn 56, Issue 3, 2013, Pages 625-627

  Silvestri, Romano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; UREA DERIVATIVE; VINBLASTINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL GROWTH; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; HYDROGEN BONDING; STRUCTURE-ACTIVITY RELATIONSHIP; VINBLASTINE;

EID: 84873886062     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400002j     Document Type: Review

References (5)

1. Leggans, E. K.; Duncan, K. K.; Barker, T. J.; Schleicher, K. D.; Boger, D. L. A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20′ urea derivatives. J. Med. Chem. 2012, DOI: 10.1021/jm3015684.
2. Jordan, M. A.; Wilson, L. Microtubules as a target for anticancer drugs Nat. Rev. Cancer 2004, 4, 253-265
3. Hamel, E.; Covell, D. G. Antimitotic peptides and depsipeptides Curr. Med. Chem.: Anti-Cancer Agents 2002, 2, 19-53
4. Carlson, R. O. New tubulin targeting agents currently in clinical development Expert Opin. Invest. Drugs 2008, 17, 707-722
5. Biersack, B.; Schobert, R. Indole compounds against breast cancer: recent developments Curr. Drug Targets 2012, 13, 1705-1719